Scientific and Medical Equipment House Company (TADAWUL:4014)
40.95
-0.35 (-0.85%)
Apr 28, 2025, 2:45 PM AST
TADAWUL:4014 Income Statement
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
Revenue | 877.23 | 776.67 | 713.82 | 699.45 | 617.47 | Upgrade
|
Revenue Growth (YoY) | 12.95% | 8.80% | 2.05% | 13.28% | 3.43% | Upgrade
|
Cost of Revenue | 744.07 | 647.92 | 560.04 | 546.7 | 467.03 | Upgrade
|
Gross Profit | 133.16 | 128.75 | 153.78 | 152.75 | 150.45 | Upgrade
|
Selling, General & Admin | 82.9 | 75.69 | 78.18 | 65.89 | 63.62 | Upgrade
|
Operating Expenses | 78.33 | 54.18 | 117.61 | 70.36 | 63.62 | Upgrade
|
Operating Income | 54.83 | 74.56 | 36.17 | 82.39 | 86.83 | Upgrade
|
Interest Expense | -25.32 | -24.91 | -19.65 | -12.95 | -12.55 | Upgrade
|
Interest & Investment Income | - | - | 0.05 | 0.33 | 0.35 | Upgrade
|
Other Non Operating Income (Expenses) | 16.3 | 12.5 | 11.08 | 14.84 | 6.69 | Upgrade
|
EBT Excluding Unusual Items | 45.8 | 62.15 | 27.65 | 84.62 | 81.32 | Upgrade
|
Gain (Loss) on Sale of Assets | 0.09 | 0.01 | 0.09 | 0.22 | 0.23 | Upgrade
|
Pretax Income | 45.89 | 62.16 | 27.74 | 84.83 | 81.55 | Upgrade
|
Income Tax Expense | 14.65 | 15.14 | 12.12 | 8.09 | 7.39 | Upgrade
|
Earnings From Continuing Operations | 31.23 | 47.02 | 15.62 | 76.75 | 74.16 | Upgrade
|
Earnings From Discontinued Operations | -6.63 | -9.22 | - | - | - | Upgrade
|
Net Income to Company | 24.61 | 37.8 | 15.62 | 76.75 | 74.16 | Upgrade
|
Minority Interest in Earnings | 1.56 | 2.26 | 1.95 | 0.78 | 0.6 | Upgrade
|
Net Income | 26.17 | 40.06 | 17.57 | 77.52 | 74.76 | Upgrade
|
Net Income to Common | 26.17 | 40.06 | 17.57 | 77.52 | 74.76 | Upgrade
|
Net Income Growth | -34.67% | 128.04% | -77.34% | 3.70% | 5.79% | Upgrade
|
Shares Outstanding (Basic) | 30 | 30 | 30 | 30 | 30 | Upgrade
|
Shares Outstanding (Diluted) | 30 | 30 | 30 | 30 | 30 | Upgrade
|
EPS (Basic) | 0.87 | 1.34 | 0.59 | 2.58 | 2.49 | Upgrade
|
EPS (Diluted) | 0.87 | 1.34 | 0.59 | 2.58 | 2.49 | Upgrade
|
EPS Growth | -34.67% | 128.04% | -77.34% | 3.70% | 5.79% | Upgrade
|
Free Cash Flow | 281.35 | -155.51 | 133.46 | -79.49 | 94.34 | Upgrade
|
Free Cash Flow Per Share | 9.38 | -5.18 | 4.45 | -2.65 | 3.15 | Upgrade
|
Dividend Per Share | - | 1.000 | - | 0.667 | 1.000 | Upgrade
|
Dividend Growth | - | - | - | -33.33% | - | Upgrade
|
Gross Margin | 15.18% | 16.58% | 21.54% | 21.84% | 24.37% | Upgrade
|
Operating Margin | 6.25% | 9.60% | 5.07% | 11.78% | 14.06% | Upgrade
|
Profit Margin | 2.98% | 5.16% | 2.46% | 11.08% | 12.11% | Upgrade
|
Free Cash Flow Margin | 32.07% | -20.02% | 18.70% | -11.36% | 15.28% | Upgrade
|
EBITDA | 64.9 | 85.87 | 47.73 | 91.47 | 93.14 | Upgrade
|
EBITDA Margin | 7.40% | 11.06% | 6.69% | 13.08% | 15.08% | Upgrade
|
D&A For EBITDA | 10.07 | 11.31 | 11.56 | 9.08 | 6.31 | Upgrade
|
EBIT | 54.83 | 74.56 | 36.17 | 82.39 | 86.83 | Upgrade
|
EBIT Margin | 6.25% | 9.60% | 5.07% | 11.78% | 14.06% | Upgrade
|
Effective Tax Rate | 31.94% | 24.35% | 43.70% | 9.53% | 9.07% | Upgrade
|
Advertising Expenses | 0.03 | 0.01 | 0.27 | 0.22 | 0.07 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.